Societies combine to issue recommendations on use of incretin drugs in obesity therapy

Дата публикации: 09-07-2026 19:40:09

Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use of obesity drugs for weight loss treatment. The statement, which is published in The Lancet Diabetes & Endocrinology, is led by Dr. Laurence Dobbie of the Department of Population Health Sciences, King's College London, with an international team of 26 authors.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Heart risk markers in adults over 40 with obesity increasingly converge with normal BMI levels	0	7	01-07-2026
2	Weight‑loss jabs may create a new kind of yo‑yo dieting	0	7	10-07-2026
3	GLP-1 'secret shopper' study finds gaps in online prescribing	0	5	07-07-2026
4	Statins and blood pressure drugs changing health risks of obesity, study suggests	0	7	01-07-2026
5	Thousands with liver disease set to be prescribed weight-loss jab Wegovy, UK drugs watchdog announces	0	7	03-07-2026
6	GLP-1 use hits record high as Medicare opens access to weight-loss drugs	0	7	09-07-2026
7	New treatment helps achieve a healthier BMI in people with weight dysregulation after brain tumors	5	7	09-07-2026
8	Stronger focus on nutrition needed in eating disorder recovery	0	7	01-07-2026
9	Battle of the diet pills: Everything you need to know about the new daily tablets - from side effects to cost. And crucially... which one will help you lose the most weight	0	7	29-06-2026
10	Women over 50 lost 35% more weight with this surprising combo	2	7	24-03-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7. Источник: medicalxpress.com.